Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bluebird Bio
company
Funding Round
Post-IPO Equity
Money Raised
$ 113.55M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jul 25, 2012 | Series D | $ 60M | ARCH Venture Partners,ArmaVir Partners,etc. | Detail |
| Apr 20, 2011 | Series C | $ 30M | ARCH Venture Partners,Easton Capital,etc. | Detail |
| Jun 17, 2004 | Series A | $ 8.50M | ABN AMRO Fund,Nazem and Company | Detail |
| Oct 27, 2012 | Series Unknown | $ 9.30M | California Institute for Regenerative Medicine | Detail |
| Mar 12, 2010 | Series B | $ 35M | Easton Capital,Forbion Capital Partners,etc. | Detail |
| Dec 7, 2016 | Post-IPO Equity | $ 250M | Detail | |
| Oct 7, 2004 | Series Unknown | $ 12M | ABN AMRO Fund,Easton Capital,etc. | Detail |
| Mar 16, 2011 | Grant | $ 4.20M | Detail | |
| Sep 8, 2021 | Post-IPO Equity | $ 75M | Detail | |
| Jun 14, 2019 | IPO | 0 | Detail |
